Atlas Trials

A Phase II Trial Assessing Nivolumab in Class II Expressing Microsatellite Stable Colorectal Cancer

Clinical trial NCT03981146 · COMPLETED

Trial details

NCT number
NCT03981146
Sponsor
University of Birmingham
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Colorectal Cancer
Start date
2019-08-28
Primary completion
2024-11-26
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.